neuroblastoma

US WorldMeds' Iwilfin bags FDA nod as 1st oral maintenance treatment for high-risk neuroblastoma
Fierce Pharma
Thu, 12/14/23 - 10:52 pm
US WorldMeds
Iwilfin
FDA
neuroblastoma
FDA Guidance Raises Concerns about Y-mAbs’ Neuroblastoma Treatment before Adcomm
BioSpace
Thu, 10/27/22 - 10:59 am
FDA
Y-mAbs Therapeutics
neuroblastoma
omburtamab
Y-mAbs pushes back re-submission of its neuroblastoma BLA to end of 2021
Endpoints
Wed, 06/23/21 - 10:41 am
Y-mAbs Therapeutics
neuroblastoma
FDA
omburtamab
Several weeks after getting hit with an RTF, Y-mAbs lands approval for its other neuroblastoma candidate
Endpoints
Mon, 11/30/20 - 10:36 am
Y-mAbs
neuroblastoma
FDA
naxitamab-gqgk
FDA hands Y-mAbs refusal to file letter in one of its pediatric neuroblastoma programs
Endpoints
Tue, 10/6/20 - 10:54 am
Y-mAbs
FDA
neuroblastoma
omburtamab
RTF letters
Antibody-drug conjugate against ALK could selectively treat neuroblastoma
BioCentury
Thu, 03/14/19 - 11:09 pm
CHOP
Celldex
neuroblastoma
dinutuximab
antibody-drug conjugate
Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA
Xconomy
Tue, 08/28/18 - 10:20 am
Y-mAbs
IPOs
pediatric cancer
FDA
neuroblastoma
FDA approves United Therapeutics' drug for children's cancer
Yahoo/Reuters
Tue, 03/10/15 - 01:16 pm
FDA
United Therapeutics
Unituxin
neuroblastoma